'la Caixa' Foundation will provide €100,000 to the IrsiCaixa project, which aims to establish a diagnostic tool to better identify infections caused by HIV, SARS-CoV-2 and Mycobacterium tuberculosis...
ADmit Therapeutics has received an investment of 497.652$ from the ADDF Diagnostics Accelerator for the development of its early Alzheimer’s disease diagnostic test in blood samples. The Diagnost...
The Supramolecular Chemistry group from the Institute for AdvancedChemistry of Catalonia (IQAC) belonging to the Spanish NationalResearch Council (CSIC) has been awarded with a project led by...
Protein Alternatives S.L. (PROALT) has begun the clinical validation study of its blood-based diagnostic test for colorectal cancerin Luminex® and ELISA-based formats. COLODETECT® test is based on...
Cancer is regarded as the disease of the 21st century as its incidence has been increasing during the last years. There is also a growing concern about this disease as there is still no specific cause...